Diagnostic Test Portfolio

Protagen is developing generic & proprietary tests to enable physicians to accurately diagnose patients who have critical autoimmune diseases, such as RA, SLE, SSc and others, earlier in the disease progression, which will enable earlier treatment and improve long-term outcomes. We are also developing tests to enable patient stratification, prognosis and disease-modified therapy response prediction, all with the goal of improving individualized patient care.

Multilisa SSc

Systemic sclerosis (SSc; also termed scleroderma) is a rare, complex, multi-organ autoimmune disease which manifests as progressive fibrosis of the skin and internal organs and has a high unmet diagnostic need.

Multilisa SLE

Utilizing 5 newly-discovered, proprietary biomarkers alongside established auto-antigens, Protagen has created more sensitive and specific diagnostic tests.